 Actavis PLC Chief Executive Brent Saunders, the drug industry’s most prolific deal maker this year, must now become one of Big Pharma’s best managers.. In little more than a year, Mr. Saunders has engineered more than $100 billion in mergers and acquisitions, most recently an agreement to buy Botox maker Allergan Inc. for $66 billion. The result: one of the world’s biggest drug companies and all the challenges that come with running one.